Clements Warren, Joseph Tim, Koukounaras Jim, Goh Gerard S, Moriarty Heather K, Mathew Joseph, Phan Tuan D
Department of Radiology, Alfred Health, 55 Commercial Road, Melbourne, VIC, 3004, Australia.
Department of Surgery, Monash University, Melbourne, Australia.
CVIR Endovasc. 2020 Dec 7;3(1):92. doi: 10.1186/s42155-020-00185-4.
As an adjunct to non-operative management, splenic artery embolization (SAE) has been increasingly utilized throughout the world and is now the standard of care for hemodynamically stable patients. This study aimed to retrospectively assess the rate of splenic salvage and complications after SAE for blunt trauma at a level 1 trauma center using the 2018 update to the AAST criteria, and further sub-stratify the role of angiography in AAST grade III injuries with significant hemoperitoneum. All patients between 1 January 2009 and 1 January 2019 who underwent blunt trauma and proceeded to embolization were included. Data was collected concerning initial injury grade, location of embolization, type of embolic material used, complications, and need for subsequent splenectomy. Technical success was defined as successful angiographic occlusion of the target artery at the conclusion of embolization. Clinical success was defined as splenic salvage at discharge. Vascular lesions were characterized including those with active bleeding, pseudoaneurysm, and arterio-venous fistula.
Two hundred thirty-two patients were included in the study. Treatments were performed at a median of 0 days (range 0-28 days) and the median AAST grade was IV (range III-V). Technical success was achieved in all patients. There were 13 complications (5.6%) consisting of re-bleed (9, 3.9%), infarction (3, 1.3%), and access site haematoma (1, 0.43%). Clinical success was achieved in 97% of patients with 7 patients requiring splenectomy after SAE (3.0%) at a median time of 4 days (range 0-17 days). Angiography in patients with grade III injuries identified 18 occult vascular injuries not identified at initial CT (p < 0.0001).
The SPLEEN-IN study shows that treatment of intermediate-high grade blunt force traumatic splenic injuries using SAE resulted in a low rate of complication and splenic salvage in 97% of patients, providing a safe and effective treatment in stable patients. In addition, angiography of grade III injuries identified occult vascular lesions and may warrant treatment of select patients in this cohort.
Level 3.
作为非手术治疗的辅助手段,脾动脉栓塞术(SAE)在全球范围内的应用越来越广泛,现已成为血流动力学稳定患者的标准治疗方法。本研究旨在使用2018年更新的美国创伤外科学会(AAST)标准,回顾性评估一级创伤中心SAE治疗钝性脾外伤后的脾挽救率和并发症,并进一步分层分析血管造影在伴有大量血腹的AAST III级损伤中的作用。纳入了2009年1月1日至2019年1月1日期间所有遭受钝性外伤并接受栓塞治疗的患者。收集了有关初始损伤分级、栓塞部位、所用栓塞材料类型、并发症以及后续脾切除术需求的数据。技术成功定义为栓塞结束时目标动脉造影成功闭塞。临床成功定义为出院时脾得以保留。对血管损伤进行了特征描述,包括有活动性出血、假性动脉瘤和动静脉瘘的损伤。
本研究共纳入232例患者。治疗中位时间为0天(范围0 - 28天),AAST分级中位数为IV级(范围III - V级)。所有患者均取得技术成功。发生13例并发症(5.6%),包括再次出血(9例,3.9%)、梗死(3例,1.3%)和穿刺部位血肿(1例,0.43%)。97%的患者获得临床成功,7例患者在SAE后需要行脾切除术(3.0%),中位时间为4天(范围0 - 17天)。III级损伤患者的血管造影发现了18例初始CT未发现的隐匿性血管损伤(p < 0.0001)。
SPLEEN - IN研究表明,使用SAE治疗中 - 高级别钝性脾外伤导致并发症发生率较低,97%的患者脾得以保留,为稳定患者提供了一种安全有效的治疗方法。此外,III级损伤的血管造影发现了隐匿性血管病变,可能需要对该队列中的部分患者进行治疗。
3级。